Home > Beauty Information >

2'-Fucosyllactose (2'-FL): From Lab to Life - A Deep Dive into Production and Applications

2'-FL CAS:41263-94-9,CAS:6155-68-6,CAS:63231-63-0

Introduction to 2'-Fucosyllactose (2'-FL)

2'-Fucosyllactose, commonly abbreviated as 2'-FL, is a complex carbohydrate and the most abundant oligosaccharide found in human breast milk. Chemically, it is a trisaccharide composed of fucose, galactose, and glucose. Its unique structure, characterized by an α-1,2 linkage between fucose and galactose, is central to its biological functions. The compound is identified by the Chemical Abstracts Service (CAS) number 41263-94-9, which is crucial for its unambiguous identification in scientific literature, regulatory filings, and commercial transactions. As a human milk oligosaccharide (HMO), 2'-FL is not digested by infants but serves as a prebiotic, selectively nourishing beneficial gut bacteria like Bifidobacteria. Its significance extends beyond nutrition; it acts as a decoy receptor for pathogens, preventing their adhesion to the infant's gut lining, thereby bolstering immune defenses and reducing infection risk. The applications of 2'-FL are rapidly expanding from its primary role in infant nutrition to adult dietary supplements, functional foods, and even pharmaceutical explorations, driven by growing scientific validation of its health benefits.

Production Methods of 2'-FL

The journey of 2'-FL from a scientific curiosity to a commercially viable ingredient involves several production pathways, each with distinct advantages and challenges.

Chemical Synthesis of 2'-FL (CAS: 41263-94-9)

Chemical synthesis involves constructing the 2'-FL molecule through a series of controlled organic reactions. This method, which yields the compound with the specific identifier CAS:41263-94-9, allows for precise control over the stereochemistry of the fucosidic linkage. However, it is typically complex, involving multiple protection and deprotection steps, costly reagents, and often results in low overall yields. It generates significant chemical waste, making it less environmentally sustainable and economically unfeasible for large-scale production required by the food and infant formula industries. Nonetheless, chemical synthesis remains vital for producing high-purity reference standards used in analytical quality control.

Enzymatic Synthesis of 2'-FL

Enzymatic synthesis offers a more specific and greener alternative. It utilizes purified enzymes, such as fucosyltransferases, to catalyze the transfer of a fucose moiety from a donor molecule (like guanosine diphosphate-fucose, GDP-fucose) to lactose. This process is highly regioselective and stereospecific, producing the desired α-1,2 linkage with minimal by-products. The challenge lies in the high cost and instability of the enzymes and the donor substrates. Innovations in enzyme engineering and immobilization are actively pursued to enhance the efficiency and reusability of biocatalysts in this process.

Fermentation-based Production of 2'-FL

Microbial fermentation is the predominant method for industrial-scale 2'-FL production. Genetically engineered microorganisms, such as specific strains of E. coli or Bacillus subtilis, are used as cellular factories. These microbes are modified to express the entire biosynthetic pathway for 2'-FL, converting simple carbon sources like glucose or glycerol into the target HMO. This method is highly scalable, cost-effective, and aligns with sustainable biomanufacturing principles. A key advancement involves the use of engineered strains that efficiently produce the fucose donor GDP-fucose intracellularly, a process linked to intermediates like CAS:6155-68-6 (a CAS number associated with fucose or its derivatives used in related metabolic pathways).

Comparison of Different Production Methods

The table below summarizes the key aspects of each production method:

Method	Advantages	Disadvantages	Suitability
Chemical Synthesis	High purity, precise stereochemistry	Low yield, high cost, environmental burden	Lab-scale, reference standards
Enzymatic Synthesis	High specificity, mild conditions	Expensive enzymes/substrates, scalability challenges	Specialty, high-value products
Microbial Fermentation	Highly scalable, cost-effective, sustainable	Complex downstream purification, genetic engineering required	Industrial mass production

Quality Control and Analysis of 2'-FL

Ensuring the purity, safety, and consistency of 2'-FL, whether produced via fermentation or other means, is paramount for its use in sensitive applications like infant formula. Rigorous quality control protocols are employed.

Determining Purity and Identity

The identity of 2'-FL is confirmed against the authentic standard (CAS:41263-94-9) using advanced spectroscopic and chromatographic techniques. Nuclear Magnetic Resonance (NMR) spectroscopy, particularly 1H and 13C NMR, provides definitive structural elucidation, confirming the α-1,2 linkage. Mass spectrometry (MS) is used to confirm the molecular weight and fragmentation pattern. These methods ensure the product is genuine 2'-FL and not isomeric impurities.

Analytical Techniques for Quantification

High-Performance Liquid Chromatography (HPLC) coupled with various detectors is the workhorse for quantification. Common setups include:

HPLC with Refractive Index (RI) Detection: A universal method for carbohydrate analysis.
HPLC with Charged Aerosol Detection (CAD) or Evaporative Light Scattering Detection (ELSD): Offers better sensitivity for compounds with weak UV absorption.
HPLC with Mass Spectrometry (LC-MS/MS): Provides the highest specificity and sensitivity, capable of detecting and quantifying 2'-FL even in complex matrices like infant formula or biological samples.

These methods are also used to monitor and quantify process-related impurities or by-products, which may include other saccharides or fermentation residues.

Regulatory Standards and Quality Control Measures

In regions like Hong Kong, which follows stringent international standards, 2'-FL as a novel food ingredient is subject to rigorous safety assessments. Regulatory bodies require comprehensive dossiers detailing production methods (including the genetic stability of production strains), purity specifications (often requiring >95% purity), and toxicological studies. For instance, a recent market survey in Hong Kong indicated that all approved infant formulas containing 2'-FL must declare its specific addition level and comply with food safety standards outlined in the Public Health and Municipal Services Ordinance (Cap. 132). Quality control measures extend to the entire supply chain, from raw material testing (including substrates referenced by codes like CAS:63231-63-0, which may pertain to specialized culture media components) to final product batch release testing for contaminants like heavy metals, microbes, and allergens.

Applications of 2'-FL

The proven bioactivities of 2'-FL have catalyzed its integration into diverse product categories aimed at improving human health across the lifespan.

Infant Formula: Improving Infant Gut Health and Immunity

This remains the flagship application. Adding 2'-FL to infant formula aims to bridge the compositional gap with human milk. Clinical studies, some conducted in Asian populations, have demonstrated that formula supplemented with 2'-FL supports a gut microbiota composition closer to that of breastfed infants, with higher levels of beneficial Bifidobacteria. This is associated with:

Softer stools and reduced crying time.
Lower incidence of respiratory infections and diarrhea.
Modulation of immune markers, promoting a balanced immune response.

Its role as a soluble decoy receptor for pathogens like norovirus and Campylobacter is a key mechanism for its protective effects.

Dietary Supplements: Promoting Gut Health in Adults

The prebiotic effect of 2'-FL is not limited to infants. Adult dietary supplements featuring 2'-FL are emerging to support gut barrier function, modulate the adult microbiome, and potentially alleviate conditions like irritable bowel syndrome (IBS). Its ability to selectively stimulate bifidobacteria can help restore microbial balance disrupted by diet, antibiotics, or stress.

Functional Foods and Beverages: Enhancing Nutritional Value

2'-FL is being incorporated into a wide array of functional products:

Dairy Products: Yogurts, fermented milks, and milk powders for all ages.
Beverages: Health drinks, sports nutrition shakes, and cereal-based drinks.
Bakery and Snacks: As a stable, sweet-tasting ingredient that adds functional fiber.

These products market the benefits of digestive health and immune support to health-conscious consumers.

Pharmaceutical Applications: Exploring Therapeutic Potential

Beyond nutrition, 2'-FL is being investigated for therapeutic applications. Preclinical research explores its potential in:

Anti-adhesion Therapy: As a prophylactic or therapeutic agent against specific enteric pathogens.
Inflammatory Bowel Disease (IBD): Modulating gut inflammation and promoting mucosal healing.
Oncology: Some studies suggest HMOs may influence cancer cell adhesion and proliferation.
Neurohealth: Exploring the gut-brain axis, with potential implications for cognitive function.

The high-purity material required for such studies often relies on controlled synthesis or purification processes, where intermediates or related standards like CAS:6155-68-6 and CAS:63231-63-0 play roles in research and development workflows.

Challenges and Future Trends in 2'-FL Production

Despite significant progress, the 2'-FL industry faces hurdles and is poised for transformative innovations.

Overcoming Challenges in Scaling Up

The primary challenge in fermentation-based production is achieving high titers, yields, and productivity to meet soaring global demand cost-effectively. This involves:

Strain Engineering: Further optimizing microbial chassis to reduce metabolic burden, eliminate by-product formation, and enhance carbon flux towards 2'-FL synthesis.
Process Optimization: Advanced bioreactor design, fed-batch strategies, and precise control of fermentation parameters (pH, dissolved oxygen).
Downstream Processing: Developing efficient, scalable, and cost-effective purification methods to isolate 2'-FL from the complex fermentation broth is a major bottleneck. Innovations in membrane filtration, chromatography, and crystallization are critical.

Innovations in Synthesis and Purification

Future trends include:

Cell-Free Biosynthesis: Utilizing purified enzyme cascades in vitro, bypassing cellular constraints, for more controllable and efficient synthesis.
Advanced Purification Technologies: Employing simulated moving bed (SMB) chromatography, continuous crystallization, and novel adsorbent materials to improve purity and reduce costs.
Sustainable Feedstocks: Shifting from food-grade sugars to non-food biomass or waste streams as fermentation substrates to enhance sustainability.

Exploring New Applications

The application horizon for 2'-FL is broadening. Research is exploring its use in:

Pet Nutrition: To support gut health in companion animals.
Cosmeceuticals: Leveraging its prebiotic and anti-inflammatory properties for skin health.
Precision Nutrition: Developing tailored HMO blends based on individual microbiome profiles.
Synbiotics: Combining 2'-FL with specific probiotic strains for enhanced synergistic effects.

The Expanding Role of 2'-FL

2'-Fucosyllactose has successfully transitioned from a fascinating component of human milk to a commercially significant biobased ingredient. The current state is characterized by robust fermentation-based production, stringent quality control aligned with global standards (exemplified by markets like Hong Kong), and well-established applications in infant nutrition that are backed by growing clinical evidence. Its potential to improve human health and nutrition is substantial, offering a natural, science-backed tool to modulate the gut microbiome and immune system from infancy through adulthood. Looking ahead, future research will likely delve deeper into its structure-function relationships, uncover new therapeutic avenues, and drive down production costs through biotechnological breakthroughs. The convergence of synthetic biology, advanced manufacturing, and nutritional science promises to further solidify the role of 2'-FL, identified unequivocally as CAS:41263-94-9, as a cornerstone of functional ingredients for the 21st century, improving health outcomes across populations and age groups.

2\'-Fucosyllactose HMO Gut Health